Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1

Conditions

Lung Neoplasms 4Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1Carcinoma, Non-Small-Cell Lung 1

Interventions

antitumor A 1X-Rays 1Tomography, Optical Coherence 1Sulindac 1Sugars 1Microarray Analysis 1Inositol 1Immunohistochemistry 1Immunoenzyme Techniques 1Iloprost 1Epoetin Alfa 1Diagnosis, Computer-Assisted 1DNA Methylation 1Cytological Techniques 1Comparative Genomic Hybridization 1Calcitriol 1Budesonide 1Bronchoscopy 1Bronchoalveolar Lavage 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Iloprost × Thoracic × Clear all
NCT00084409 2020-05-14

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

University of Colorado, Denver

Phase 2 Completed
152 enrolled 18 charts
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡